Stephen D. Emond John R. Cooke J. Stephan Stapczynski
Pathophysiology. oLThrombosis Agents
Oral, Anticoagulants Parenteral Anticoagulants
Blockers.. of ..Platelet Activation BiockersofPiatelei, ..Aggregation Fibrinolytic, Agents
Indications .forAntithrombotic. Therapy Acute.. Myocardia.! .Infarction
Deep. venous. .Xh,romb.osis..o,r .£ulm2nary..E.mboli.s,m
Cpmpljcationsof Anticoagulation .a.nd...Antithrom.boticM Therapy
Antithrombotic therapy is standard for numerous arterial and venous thromboembolic conditions, including acute myocardial infarction (AMI), unstable angina pectoris, deep venous thrombosis (DVT), pulmonary embolism (PE), and stroke or cerebrovascular accident (CVA). Moreover, antithrombotic agents help prevent occlusive vascular disease in patients at risk for thrombosis. These agents, however, also have the potential to cause life-threatening complications, primarily uncontrolled hemorrhage. This chapter provides an overview of antithrombotic agents, including mechanisms, indications, contraindications, and therapies, as well as evaluation and management of acute bleeding complications. Detailed management of thromboembolic disorders is discussed in their respective chapters.
Was this article helpful?
This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.